Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate Tablet
Product Images NDC 87441-003

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate (NDC 87441-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

002-01 (87441 002 01 Converted)

Label for Buprenorphine and Naloxone Sublingual Tablets, USP, strength 8 mg/2 mg, in tablet form for sublingual use. The label includes dosing instructions referencing a medication guide. The product is repackaged by Unit Dose Solutions, Inc. and distributed by Tuckahoe Enterprises, LLC. Storage instructions specify 20° to 25°C (68° to 77°F). The label also warns to keep out of reach of children.*

FDA Label Image

003-01 (87441 003 01 Converted)

Label for Buprenorphine and Naloxone Sublingual Tablets, USP, 2 mg/0.5 mg strength. The label indicates it is Rx only with directions for pharmacists to dispense the medication guide. It includes storage instructions and warnings to keep out of reach of children. The product is repackaged by Unit Dose Solutions, Inc. and distributed by Tuckahoe Enterprises, LLC.*

FDA Label Image

Buprenorphine Chemical Structure (Buprenorphine HCl And Naloxone HCl Dihydrate Subli 1)

Chemical structure diagram of Buprenorphine Hydrochloride representing the molecular composition and arrangement of atoms in the active ingredient.*

FDA Label Image

Naloxone Chemical Structure (Buprenorphine HCl And Naloxone HCl Dihydrate Subli 2)

Chemical structure diagram of Buprenorphine Hydrochloride and Naloxone Hydrochloride Dihydrate active ingredients, showing molecular connectivity and key functional groups typically found in these compounds.*

FDA Label Image

Mouth (Buprenorphine HCl And Naloxone HCl Dihydrate Subli 3)

An instructional diagram showing a person placing a sublingual tablet under the tongue using fingers. The mouth is open wide, revealing the tongue and teeth, demonstrating the proper placement of the sublingual tablet for absorption.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.